Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Alexandria Real Estate Equities (ARE) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 8,814,950
  • Shares Outstanding, K 77,970
  • Annual Sales, $ 843,470 K
  • Annual Income, $ 144,220 K
  • 36-Month Beta 0.86
  • Price/Sales 10.45
  • Price/Book 2.17

Price Performance

See More
Period Period Low Period High Performance
1-Month
103.32 +6.39%
on 11/14/16
114.02 -3.60%
on 11/29/16
+0.86 (+0.79%)
since 11/09/16
3-Month
101.51 +8.28%
on 10/11/16
114.67 -4.14%
on 09/27/16
+3.61 (+3.40%)
since 09/09/16
52-Week
70.69 +55.50%
on 02/12/16
114.67 -4.14%
on 09/27/16
+20.69 (+23.19%)
since 12/09/15

Most Recent Stories

More News
Alexandria Real Estate, Merck Ink Long-Term Pharma Lease

Alexandria Real Estate Equities, Inc. (ARE) has announced its tie up with Merck & Co., Inc. (MRK) to operate its new West Coast research facility.

Alexandria Real Estate Equities, Inc. Announces Long-Term 294,000 RSF, Full-Building, Build--to--Suit Lease for Merck's New West Coast Research Facility at 213 East Grand Avenue in South San Francisco

Alexandria Real Estate Equities, Inc. (NYSE: ARE), a real estate investment trust uniquely focused on world-class collaborative science and technology campuses in urban innovation clusters, announced today...

Zacks.com featured highlights: Lancaster Colony, Sucampo Pharmaceuticals, VMware and Alexandria Real Estate Equities

Zacks.com featured highlights: Lancaster Colony, Sucampo Pharmaceuticals, VMware and Alexandria Real Estate Equities

4 Stocks to Buy on Solid Earnings Acceleration

If the rate of a company's quarter-over-quarter earnings growth increases over a considerable period, it is termed as earnings acceleration.

Terreno Realty (TRNO) Continues Its Acquisition Spree

Terreno Realty Corporation (TRNO) announced the acquisition of an industrial property located in Carlstadt, NJ on Nov 16.

STAG Industrial Sells Six Industrial Real Estate Properties

STAG Industrial, Inc. (STAG) has closed the sale of Southeast Portfolio for a gross proceed of around $81 million.

PREIT Adds ULTA Beauty and DSW at Mall at Prince Georges

PREIT (PEI) executed two leases at Mall at Prince Georges in suburban Washington, D.C. As part of its $30 million remerchandising and renovation program.

Simon Property (SPG) to Sell Senior Notes Totaling $1.85B

Simon Property Group Inc. (SPG) has agreed to sell three tranches of senior notes totaling $1.85 billion.

Corporate Office Properties Starts Build-to-Suit Project

Corporate Office Properties (OFC) commenced a 215,000 square feet build-to-suit project on land in Manassas, VA, for a strategic tenant.

Vornado (VNO) Extends $1.25B Revolving Credit Facility

Vornado Realty Trust (VNO) has made the announcement of extending one of its two $1.25 billion unsecured revolving credit facilities.

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Alexandria Real Estate Equities, Inc., Landlord and Developer of Choice to the Life Science Industry, is a publicly-traded real estate investment trust focused principally on the ownership, operation, management, selective redevelopment, development and acquisition of life science properties. Our properties...

See More

Support & Resistance

2nd Resistance Point 111.99
1st Resistance Point 110.95
Last Price 109.92
1st Support Level 109.04
2nd Support Level 108.17

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.